We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10.11%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$47.1B
AUM Growth
+$2.61B
Cap. Flow
-$501M
Cap. Flow %
-1.06%
Top 10 Hldgs %
14.43%
Holding
3,576
New
705
Increased
706
Reduced
825
Closed
988

Top Buys

Rank Stock Value
1
WMT icon
Walmart Inc
WMT
+$417M
2
META icon
Meta Platforms (Facebook)
META
+$383M
3
AMZN icon
Amazon
AMZN
+$308M
4
MSFT icon
Microsoft
MSFT
+$293M
5
GE icon
GE Aerospace
GE
+$263M

Top Sells

Rank Stock Value
1
CI icon
Cigna
CI
+$312M
2
BAC icon
Bank of America
BAC
+$292M
3
XOM icon
ExxonMobil
XOM
+$274M
4
LULU icon
lululemon athletica
LULU
+$238M
5
QCOM icon
Qualcomm
QCOM
+$228M

Sector Composition

Rank Sector Weight
1 Healthcare 17.05%
2 Technology 14.35%
3 Consumer Discretionary 13.97%
4 Financials 9.9%
5 Industrials 6.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRLH
751
DELISTED
Pearl Holdings Acquisition Corp Class A Ordinary Shares
PRLH
$8.5M 0.02%
813,856
ICNC.WS
752
CALL
DELISTED
Iconic Sports Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
ICNC.WS
$8.49M 0.02%
808,264
VAL icon
753
Valaris
VAL
$5.43B
$8.48M 0.02%
130,272
+101,300
+350% +$7.06M
CIEN icon
754
Ciena
CIEN
$53.4B
$8.46M 0.02%
161,137
-155,763
-49% -$7.78M
P
755
Everpure Inc
P
$24.7B
$8.46M 0.02%
331,585
-707,128
-68% -$19.1M
GDS icon
756
GDS Holdings
GDS
$6.29B
$8.45M 0.02%
+452,879
New +$9.59M
RENE
757
DELISTED
Cartesian Growth Corp II
RENE
$8.39M 0.02%
799,989
NOK icon
758
Nokia
NOK
$51.8B
$8.37M 0.02%
1,704,504
+183,110
+12% +$863K
DH icon
759
Definitive Healthcare
DH
$71.1M
$8.36M 0.02%
809,151
+283,688
+54% +$3.34M
EXEL icon
760
Exelixis
EXEL
$14B
$8.34M 0.02%
429,729
+56,588
+15% +$986K
SBUX icon
761
CALL
Starbucks
SBUX
$118B
$8.34M 0.02%
80,100
+61,000
+319% +$6.35M
ZLS
762
DELISTED
Zalatoris II Acquisition Corp Class A Ordinary Shares
ZLS
$8.3M 0.02%
812,447
NFE icon
763
New Fortress Energy
NFE
$96.4M
$8.28M 0.02%
281,403
-456,491
-62% -$16.1M
QCOM icon
764
CALL
Qualcomm
QCOM
$179B
$8.27M 0.02%
64,800
-3,400
-5% -$423K
NPAB
765
DELISTED
New Providence Acquisition Corp. II Class A Common Stock
NPAB
$8.21M 0.02%
791,491
CMG icon
766
CALL
Chipotle Mexican Grill
CMG
$42.6B
$8.2M 0.02%
240,000
-140,000
-37% -$4.4M
NFYS.WS
767
CALL
DELISTED
Enphys Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
NFYS.WS
$8.18M 0.02%
800,912
SLVM icon
768
Sylvamo
SLVM
$1.5B
$8.09M 0.02%
174,902
-2,429
-1% -$115K
DNLI icon
769
Denali Therapeutics
DNLI
$3.74B
$8.08M 0.02%
350,539
-610,100
-64% -$16.8M
FN icon
770
Fabrinet
FN
$16.9B
$8.06M 0.02%
67,906
-60,877
-47% -$7.57M
PNTG icon
771
Pennant Group
PNTG
$1.44B
$8.04M 0.02%
563,021
+423,897
+305% +$5.31M
JWN
772
DELISTED
Nordstrom
JWN
$8.02M 0.02%
492,972
+409,987
+494% +$7.66M
WOOF icon
773
Petco
WOOF
$777M
$8M 0.02%
888,515
+735,026
+479% +$7.61M
TWCB
774
DELISTED
Bilander Acquisition Corp. Class A Common Stock
TWCB
$7.99M 0.02%
792,052
VITL icon
775
Vital Farms
VITL
$569M
$7.98M 0.02%
521,508
+12,205
+2% +$193K

Similar funds

Marshall Wace's Q1 2023 Portfolio in Review

As of Q1 2023, Marshall Wace held 3,576 positions worth $47.1B, up 5.9% from $44.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Marshall Wace's Q1 2023 filing shows 705 new, 706 increased, 825 reduced and 988 closed positions. Its largest new stake was Madrigal Pharmaceuticals: 541,764 shares worth $131M. The largest sale was Cigna, an estimated $312M.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Marshall Wace's largest Q1 2023 buy was Madrigal Pharmaceuticals: 541,764 shares worth $131M.
  • Marshall Wace added most to Walmart Inc in Q1 2023, an estimated $417M increase.
  • Marshall Wace's biggest Q1 2023 reduction was Cigna, cutting an estimated $312M.
  • Marshall Wace fully exited Merck in Q1 2023, selling an estimated $115M.
  • Marshall Wace's ten largest holdings make up 14% of its $47.1B portfolio in Q1 2023.
  • Marshall Wace opened 705 new positions and closed 988 in Q1 2023.
  • Marshall Wace's portfolio value rose 5.9% quarter-over-quarter to $47.1B.

Based on Marshall Wace's 13F filing for Q1 2023, filed 15 May 2023.